IMDS Launches NHanceIT™ Microcatheter in the U.S. to Advance Complex PCI
Interventional Medical Device Solutions (IMDS), a specialty catheter company developing purpose-built solutions for complex PCI, CHIP, and CTO procedures, today announced the U.S. launch of NHanceIT™, an over-the-wire, single-lumen microcatheter built on proprietary Skeleton Backbone™ technology. Engineered to improve lesion crossing in challenging coronary anatomy, NHanceIT is part of the IMDS portfolio designed to address distinct procedural challenges through advanced catheter technology.
IMDS Launches Direct U.S. Operations; Appoints Jason Bottiglieri President of IMDS U.S.
Interventional Medical Device Solutions (IMDS), a global leader in precision-engineered tools for complex PCI, CHIP, and CTO procedures, today announced the launch of its direct commercial organization in the United States. To lead this expansion, IMDS has appointed veteran cardiovascular executive Jason Bottiglieri as President, IMDS U.S.
